1,499
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer

, , , , &
Pages 3581-3594 | Received 22 Jun 2020, Accepted 13 Nov 2020, Published online: 10 Dec 2020

Figures & data

Scheme 1. Schematic diagram of preparation and sustained release mechanism of the GL nanocomposite drug

Scheme 1. Schematic diagram of preparation and sustained release mechanism of the GL nanocomposite drug

Figure 1. Characterization of nanoliposome

(a): The particle size of GEB and GL; (b): PDI of GEB and GL particle size; (c): Surface Zeta potentials of GEB and GL; (d): TEM picture of GL (10000×).
Figure 1. Characterization of nanoliposome

Figure 2. Study on encapsulation efficiency and release behavior of nanoliposome

(a): GL encapsulation efficiency under different oval-biliary ratios (LE/CH); (b): Cumulative release curves of GEB and GL.
Figure 2. Study on encapsulation efficiency and release behavior of nanoliposome

Figure 3. Effects of GL on viability and apoptosis of A549 cells and 16HBE cells

(a): Effects of different concentrations of GEB and GL on viability of A549 cells and 16HBE cells; (b): Effects of GEB and GL on apoptosis of A549 cells; (c): Flow cytometry of GEB and GL on A549 cells. * P < 0.05, ** P < 0.01.
Figure 3. Effects of GL on viability and apoptosis of A549 cells and 16HBE cells

Figure 4. Colony formation, scratch and Transwell invasion assays of A549 cells

(a): Cell proliferation in the colony formation assay; (b): Cell migration ability in scratch assay (200×); (c): Cell invasion ability in Transwell assay (100×). * P < 0.05, ** P < 0.01.
Figure 4. Colony formation, scratch and Transwell invasion assays of A549 cells

Figure 5. Cell cycle comparisons among different treatment groups

(a,b): Flow cytometry diagram of tumor cell cycle after cells were treated with different concentrations of GEB and GL, respectively; (c,d): Tumor cell cycle distribution after cells were treated with different concentrations of GEB and GL, respectively; €: Distribution of tumor cell cycle after cells were treated with 50 μg/mL GEB and 50 μg/mL GL, respectively. * P < 0.05, ** P < 0.01.
Figure 5. Cell cycle comparisons among different treatment groups

Figure 6. Evaluation of anti-cancer effect in vivo of different treatment groups

(a): Tumor size curve changes over treatment time, and the treatments of GEB and GL are over 14 d (* P < 0.05, ** P < 0.01); (b): The mean tumor weights of the PBS, GEB, and GL groups after 14 d; (c): Average tumor volume after 14 d in PBS, GEB and GL groups; (d): Digital images of tumors after 14 d in PBS, GEB, and GL groups; €: Mean body weight of mice in PBS, GEB and GL groups during treatment.
Figure 6. Evaluation of anti-cancer effect in vivo of different treatment groups

Figure 7. H&E staining and immunohistochemical evaluation of tumor tissue

Optical micrographs of H&E staining and immunohistochemical indexes (Ki-67, EGFR and ER-α) of tumor tissue in PBS, GEB and GL groups are presented.
Figure 7. H&E staining and immunohistochemical evaluation of tumor tissue

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.